ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Synvista Therapeutics,

Synvista Therapeutics, (SYI)

0.00
0.00
(0.00%)
Closed January 08 3:00PM
0.00
0.00
(0.00%)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

SYI Latest News

Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE

MONTVALE, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that it has entered into agreements with the current holders of its Series...

Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update

MONTVALE, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that, following a review of its clinical development portfolio and its...

Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium

MONTVALE, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) has completed enrollment of its BENEFICIAL study, a Phase 2 double-blind...

Synvista Notified by NYSE Alternext of Continued Listing Standards Non-Compliance

Company Expects Its Common Stock to Remain Listed While it Engages in Compliance Process MONTVALE, N.J., Dec. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI...

Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline

Synvista Therapeutics Technology Provided CML Biomarker Data for Studies MONTVALE, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced...

Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis

MONTVALE, N.J., Dec. 15 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) has dosed the first patient in a 30-patient Phase 2 clinical trial of its proprietary...

Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit

MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (AMEX:SYI) today announced that it has submitted, and that the FDA has received its application for 510(k) clearance...

Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA M

New Data Presented at the Meeting Demonstrate Vitamin E May Help Prevent Cardiovascular Events in Hp2-2 Diabetes MONTVALE, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc...

Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

- Presentation to be Webcast - MONTVALE, N.J. , Nov. 10 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (AMEX:SYI) announced today that Noah Berkowitz, M.D., Ph.D., President and Chief...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

SYI - Frequently Asked Questions (FAQ)

What is the current S.Y. Bancorp share price?
The current share price of S.Y. Bancorp is US$ 0.00
What is the 1 year trading range for S.Y. Bancorp share price?
S.Y. Bancorp has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TPETTrio Petroleum Corp
US$ 2.03
(59.84%)
89.29M
EONREON Resources Inc
US$ 1.045
(30.30%)
83.01M
MLSSMilestone Scientific Inc
US$ 1.25
(21.36%)
1.86M
GOROGold Resource Corporation
US$ 0.2614
(16.07%)
10.76M
CHROChannel Therapeutics Corporation
US$ 1.01
(9.89%)
222.38k
KAPAKairos Pharma Ltd
US$ 1.00
(-33.33%)
1.06M
MTNBMatinas Biopharma Holdings Inc
US$ 0.664
(-30.82%)
2.19M
GPUSHyperscale Data Inc
US$ 4.11
(-24.73%)
138.62k
OPTTOcean Power Technologies Inc
US$ 1.085
(-23.05%)
30.5M
HCWCHealthy Choice Wellness Corp
US$ 1.27
(-20.63%)
815.91k
TPETTrio Petroleum Corp
US$ 2.03
(59.84%)
89.29M
EONREON Resources Inc
US$ 1.045
(30.30%)
83.01M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6.19
(-0.16%)
79.7M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 30.18
(-3.11%)
69.5M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.515
(-0.20%)
66.64M

Discussion

View Full Feed
fuagf fuagf 2 minutes ago
Yep, thanks President Biden for cushioning what's to come under Trump.
Just about 0.7% of voters had to appreciate what you accomplished more.
RickNagra RickNagra 2 minutes ago
Yugely yuge news.

style="white-space: pre-wrap; caret-color: rgb(255, 255, 255); color: rgba(255, 255, 255, 1); font-size: 15px; background-color: rgba(0, 0, 0, 1)"https://x.com/amacker/status/1877107832094327027

FNMA
Tiger Money Tiger Money 3 minutes ago
Tgat is exactly why I bought rgti at $1.50 as nvda went to 125 post split.  My thought was what will replace nvda monopoly as building warehouses with computers doing massive calculations and processesss is so inefficient.  So I found quantum computing but sold a lot lower than the $20 it hit becaus
KULR
SwissCheeseAccount SwissCheeseAccount 3 minutes ago
Good lord,

What the heck did I read 🤣🤣🤣

I see a lot of new post and I thought I missed something, I just see a whole lotta MUCK posted with no context or clarity 😂


Ehhhhh


Still waiting on LBT
LEHNQ
michael702/ michael702/ 3 minutes ago
Other than older post
BLLB
Humbert Humbert 3 minutes ago
Those who post libel on this board are merely attempting to mislead investors; Delex is one of the most verifiable deals we've seen in these parts
BNCM
Chartmaster Chartmaster 5 minutes ago
Nice! But I don't see a 1929 type depression in America coming, not with the new guy in office.........Elon! Lol!
BioEquity BioEquity 5 minutes ago
PIPE Investors paid $1.05/share last week! Reminder that $3.90/share is still equivalent to a $230M valuation for SNTI, vs $9M last month! Meanwhile, an institutional investor just purchased 4.2M shares and 6.3M warrants = 10.5M shares @ $1.05/share last week. Total is now ~60M shares outstanding on
SNTI
stockinspector stockinspector 5 minutes ago
Yes! Go there and buy one! And then report back.
WDLF
gitreal gitreal 6 minutes ago
JUST MAKE SENCE NOW WHY YOU DO YOU!!

Not much of what you say makes much "sence", Kate.
AABB
delerious1 delerious1 6 minutes ago
Over 12,000 OTC stocks and they're all scams?? SMH....some folks wouldn't know a good OTC bet if it bit them on the A$$
NBRI
JTHawk JTHawk 6 minutes ago
$CAPC
Share price tripled this week, announced they are clearing balance sheet of debt and getting ready for possible merger looking. Tiny floater with only 29 million and nice ss!  This will hit .10 and then keep going in upcoming weeks!  I love this one!
CAPC
weedtrader420 weedtrader420 7 minutes ago
BITCOIN said California fires remind me of Hawaii fire.🤔 $121,000 TARGET
BTCUSD
JTHawk JTHawk 7 minutes ago
$CAPC
Share price tripled this week, announced they are clearing balance sheet of debt and getting ready for possible merger looking. Tiny floater with only 29 million and nice ss!  This will hit .10 and then keep going in upcoming weeks!!!
CAPC
JTHawk JTHawk 8 minutes ago
$CAPC
Share price tripled this week, announced they are clearing balance sheet of debt and getting ready for possible merger looking. Tiny floater with only 29 million and nice ss!  This will hit .10 and then keep going in upcoming weeks!

CAPC
mrMadMax mrMadMax 8 minutes ago
You too? 🤡Don’t you realize that everything you’re writing is just BS fantasy? No one is interested. We're talking about OTC, but do you have any idea who is interested in this market? Do you think that with these theories and nonsense you keep writing, people will take you seriously? Just i
ATMH
dreamhouse33 dreamhouse33 8 minutes ago
Been a crazy ride... I'm still in, but little to no hope left.  Wish you the best, brother!
NSAV
justkate justkate 9 minutes ago
JUST CAPS IN RED?? NOW THAT IMAGE IS IN MY HEAD!! THE COLORS OF THE MAPLE LEAF!! GOOD GRIEF!! NOT YOU TOO?? JUST MAKE SENCE NOW WHY YOU DO YOU!! DO IT ALL IN RED AND MAKE IT BOLD AND ME WELL I WILL CONTINUE TO HOLD!! HOW LONG YOU ASK? WELL THANKS TO YOUR TASK!! JUST UNTIL THE EIGHT HUNDRED AND EIGHT
AABB
WhAtEvA1 WhAtEvA1 9 minutes ago
This trial represents not just a milestone for Vivos, but a pivotal moment for the entire field of oncology. We eagerly anticipate sharing preliminary results soon and comprehensive findings upon trial completion

Remember this SC8: there is a reason for the above statement IMO. The gu
RDGL
WhAtEvA1 WhAtEvA1 9 minutes ago
Deleted post
RDGL
JRoon71 JRoon71 9 minutes ago
Yup, that's messed up. It sort of boggles my mind how Amarin lets this stuff go on.
AMRN
Viking61 Viking61 10 minutes ago
Horseman, it looks like we’re blowing right through $5 and above $6 come Friday!! Up Up and away🚀
FNMA
dreamhouse33 dreamhouse33 10 minutes ago
Wow!
NSAV
Hoskuld Hoskuld 11 minutes ago
Hosai, was just looking at the OLE Timo Grimmer abstract you posted on 12-DEC-2024. That is a sweet argument for approving 2-73 in addition to the JPAD paper. Anavex should be able to hit it out of the park at JPM if they do a good job of putting it all into context and tying it to commercial goal
JPM

Your Recent History

Delayed Upgrade Clock